Q-omics provides the consensus-scored TP53TG3E profile across patient tissues and cancer cell-line models.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for TP53TG3E — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with TP53TG3E in patient tissues and cancer cell lines. In cancer cell lines, TP53TG3E RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Lymphoma, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Leukemia.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	450	BLOOD_Lymphoma (97)	view →
Mutation	129	BLOOD_Leukemia (30)	view →